Form 4 for MED MEDIFAST INC

Accepted 2023-11-09 00:00:00 ET · period of report 2023-11-03 · accession 0001628280-23-038375 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2023-11-09	2023-11-07	MED	BROWN JEFFREY J	Dir	P - Purchase	$68.89	+58.35	5,784	+1%	+$4,020
I	2023-11-09	2023-11-03	MED	BROWN JEFFREY J	Dir	P - Purchase	$70.55	+96.74	4,233	+2%	+$6,825

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-11-07	P	A	58.35	$68.89	5,783.65	D	—	—	(F3) Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
2	Common	Common Stock	2023-11-03	P	A	96.74	$70.55	4,232.97	I Jeffrey Brown Living Trust	—	—	(F1) These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan. (F2) These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.